V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270019774 | 270007472 | null | 79.3 | Adjuvant (A) | 2017-08-25 | 2017-09-07 | FLUOROURACIL + OXALIPLATIN | null | null | 270009300 | OXALIPLATIN + MDG |
| 270019775 | 270007493 | 1.63 | null | Palliative (P) | 2018-07-31 | 2018-09-12 | Irinotecan + Modified De Gramont | null | N | 270009455 | IRINOTECAN + MDG |
| 270019776 | 270007512 | 1.67 | 100.7 | Palliative (P) | 2017-05-05 | 2018-05-20 | Capecitabine | N | N | 270009573 | CAPECITABINE |
| 270019777 | 270007523 | null | null | Adjuvant (A) | 2015-12-27 | 2016-02-02 | Capecitabine + Oxaliplatin 21day | N | N | 270009627 | CAPECITABINE + OXALIPLATIN |
| 270019778 | 270018067 | null | 84.5 | Adjuvant (A) | 2016-06-04 | 2016-06-04 | Capecitabine + Oxaliplatin 21day | 99 | N | 270009629 | CAPECITABINE + OXALIPLATIN |
| 270019779 | 270007533 | 1.87 | 92 | Adjuvant (A) | null | 2017-03-17 | Brentuximab | 2 | N | 270009706 | BRENTUXIMAB |
| 270019780 | 270019018 | null | 55 | Disease modification (D) | 2017-06-23 | 2018-05-08 | Capecitabine + Oxaliplatin 21day | N | N | 270009725 | CAPECITABINE + OXALIPLATIN |
| 270019781 | 270007575 | 1.76 | 77.5 | Palliative (P) | 2015-05-05 | 2015-11-22 | Brentuximab | 02 | N | 270009887 | BRENTUXIMAB |
| 270019782 | 270007606 | 1.79 | 88 | Adjuvant (A) | 2018-04-27 | 2018-04-29 | Capecitabine + Oxaliplatin 21day | Y | N | 270010050 | CAPECITABINE + OXALIPLATIN |
| 270019783 | 270019026 | 1.63 | 90.5 | Neo-adjuvant (N) | 2018-09-19 | 2018-09-30 | Capecitabine | N | Y | 270010099 | CAPECITABINE |
| 270019784 | 270007667 | 1.58 | 97 | Curative (C) | 2016-11-27 | 2016-11-27 | Brentuximab | 02 | N | 270010314 | BRENTUXIMAB |
| 270019785 | 270007671 | 1.58 | null | null | 2020-04-04 | 2020-04-25 | Capecitabine + Oxaliplatin 21day | N | N | 270010329 | CAPECITABINE + OXALIPLATIN |
| 270019786 | 270007673 | 1.67 | 128.2 | Adjuvant (A) | 2015-03-01 | 2015-03-08 | Brentuximab | 2 | N | 270010363 | BRENTUXIMAB |
| 270019787 | 270013623 | null | 126.2 | Curative (C) | 2019-04-18 | 2019-05-01 | Brentuximab | 2 | N | 270010408 | BRENTUXIMAB |
| 270019788 | 270007699 | 1.78 | 73.2 | Palliative (P) | 2015-11-03 | 2016-01-03 | Capecitabine | N | N | 270010476 | CAPECITABINE |
| 270019789 | 270019568 | null | 74.2 | Palliative (P) | 2015-08-06 | 2015-08-22 | Brentuximab Vedotin | 02 | N | 270010739 | BRENTUXIMAB |
| 270019790 | 270007777 | 1.86 | 94.8 | Palliative (P) | 2017-11-25 | 2018-04-04 | Brentuximab | N | N | 270010845 | BRENTUXIMAB |
| 270019791 | 270007798 | 0 | 57.6 | Neo-adjuvant (N) | 2016-09-20 | 2016-09-20 | Capecitabine | N | N | 270010933 | CAPECITABINE |
| 270019792 | 270018124 | 1.81 | 49 | Palliative (P) | 2016-04-27 | 2016-05-13 | Capecitabine | N | N | 270010948 | CAPECITABINE |
| 270019793 | 270016506 | 1.51 | 62.4 | Adjuvant (A) | 2018-06-14 | 2018-06-14 | Brentuximab Vedotin | N | N | 270010983 | BRENTUXIMAB |
| 270019794 | 270007844 | null | null | Curative (C) | 2018-06-08 | 2018-06-08 | Capecitabine + Oxaliplatin 14day | 02 | null | 270011105 | CAPECITABINE + OXALIPLATIN |
| 270019795 | 270016521 | null | 107.9 | Curative (C) | 2015-07-24 | 2015-11-27 | Brentuximab | N | null | 270011112 | BRENTUXIMAB |
| 270019796 | 270007864 | 1.66 | 77.4 | Curative (C) | 2019-04-04 | 2019-04-04 | Brentuximab | 02 | N | 270011143 | BRENTUXIMAB |
| 270019797 | 270013764 | null | null | Palliative (P) | 2018-09-08 | 2018-09-14 | Brentuximab Vedotin | N | N | 270011390 | BRENTUXIMAB |
| 270019798 | 270007961 | 1.85 | 101.4 | Curative (C) | 2017-08-30 | 2017-09-11 | Capecitabine | N | N | 270011446 | CAPECITABINE |
| 270019799 | 270007983 | 1.6 | null | Disease modification (D) | 2017-09-26 | 2017-09-27 | Brentuximab | null | null | 270011521 | BRENTUXIMAB |
| 270019800 | 270007988 | 1.7 | 74 | Curative (C) | 2018-12-08 | 2018-12-08 | Brentuximab | 02 | N | 270011533 | BRENTUXIMAB |
| 270019801 | 270008013 | 1.53 | 80.4 | Curative (C) | 2014-07-16 | 2014-07-16 | Capecitabine | 02 | N | 270011590 | CAPECITABINE |
| 270019802 | 270008033 | 1.82 | 55 | null | 2017-11-17 | 2017-12-13 | Brentuximab Vedotin | N | N | 270011646 | BRENTUXIMAB |
| 270019803 | 270008061 | 1.82 | 94.2 | Curative (C) | 2019-07-17 | 2019-09-06 | Trial Unspecified | 1 | N | 270011723 | TRIAL |
| 270019804 | 270008086 | 1.69 | 32 | Palliative (P) | 2016-03-10 | 2016-03-12 | HD EuroNet-PHL-C1 COPDAC | Y | null | 270011757 | TRIAL |
| 270019805 | 270008123 | null | null | Palliative (P) | null | 2014-12-31 | Trial Unspecified | N | null | 270011884 | TRIAL |
| 270019806 | 270008132 | null | 73.5 | Palliative (P) | 2016-03-25 | 2018-05-03 | Cetuximab 7 day (Cycle 1) | N | null | 270011914 | CETUXIMAB |
| 270019807 | 270008138 | null | 55.15 | Palliative (P) | 2016-03-05 | 2016-08-06 | Cetuximab 14 day | 02 | Y | 270011920 | CETUXIMAB |
| 270019808 | 270013871 | 1.8 | 78 | Curative (C) | 2014-06-09 | 2014-09-06 | Cetuximab 14 day | N | N | 270011935 | CETUXIMAB |
| 270019809 | 270008160 | 1.69 | 92.8 | Palliative (P) | 2014-12-24 | 2015-06-10 | CETUXIMAB | 02 | N | 270011982 | CETUXIMAB |
| 270019810 | 270008179 | 1.74 | 67 | Curative (C) | 2018-01-21 | 2018-02-19 | CETUXIMAB | 02 | N | 270012063 | CETUXIMAB |
| 270019811 | 270008195 | 1.68 | 85 | null | null | 2014-08-28 | Escalated BEACOPP | N | N | 270012098 | BEACOPP |
| 270019812 | 270008218 | 0 | 61.8 | Curative (C) | 2014-10-09 | 2014-10-09 | HD EuroNet-PHL-C1 COPDAC | N | N | 270012187 | TRIAL |
| 270019813 | 270008302 | 0 | 72.3 | Adjuvant (A) | 2015-12-26 | 2015-12-27 | COPP + Dacarbazine | 02 | N | 270012431 | COPP + DACARBAZINE |
| 270019814 | 270008318 | 0 | 55 | Curative (C) | 2016-10-28 | 2016-10-30 | COPP + Dacarbazine | null | null | 270012463 | COPP + DACARBAZINE |
| 270019815 | 270008345 | 1.8 | 51 | Curative (C) | 2014-02-17 | 2014-04-15 | Cetuximab 7 day (Cycle 1) | N | N | 270012525 | CETUXIMAB |
| 270019816 | 270008365 | 0 | 38.6 | Adjuvant (A) | 2014-02-02 | 2014-04-14 | COPP + Dacarbazine | N | N | 270012579 | COPP + DACARBAZINE |
| 270019817 | 270008380 | null | null | Curative (C) | 2017-03-14 | 2017-03-15 | Cetuximab 14 day | N | null | 270012612 | CETUXIMAB |
| 270019818 | 270008392 | 1.73 | 74 | Palliative (P) | 2017-11-11 | 2018-01-19 | Cetuximab 14 day | N | Y | 270012660 | CETUXIMAB |
| 270019819 | 270008417 | null | 96.4 | Curative (C) | 2016-12-30 | 2017-01-06 | HD EuroNet-PHL-C1 COPDAC | N | N | 270012720 | TRIAL |
| 270019820 | 270008424 | 0 | 82.3 | Adjuvant (A) | 2017-07-07 | 2017-07-09 | COPP + Dacarbazine | 2 | null | 270012726 | COPP + DACARBAZINE |
| 270019821 | 270008429 | 0 | 56.8 | Curative (C) | 2014-01-09 | 2014-01-12 | COPP + Dacarbazine | N | N | 270012737 | COPP + DACARBAZINE |
| 270019822 | 270008438 | 1.7 | 66.5 | Curative (C) | 2013-12-28 | 2014-01-10 | BEACOPP-14 | 2 | N | 270012755 | BEACOPP |
| 270019823 | 270008465 | 0 | 37.7 | Curative (C) | 2016-07-02 | 2016-07-23 | COPP + Dacarbazine | N | null | 270012832 | COPP + DACARBAZINE |